- Home
- FKWL vs INZY Comparison
FKWL vs INZY Comparison
Compare FKWL & INZY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FKWL
- INZY
- Stock Information
- Founded
- FKWL 1981
- INZY 2015
- Country
- FKWL United States
- INZY United States
- Employees
- FKWL N/A
- INZY N/A
- Industry
- FKWL Telecommunications Equipment
- INZY Biotechnology: Pharmaceutical Preparations
- Sector
- FKWL Utilities
- INZY Health Care
- Exchange
- FKWL Nasdaq
- INZY Nasdaq
- Market Cap
- FKWL 56.8M
- INZY 64.9M
- IPO Year
- FKWL 1996
- INZY 2020
- Fundamental
- Price
- FKWL $4.21
- INZY $3.97
- Analyst Decision
- FKWL
- INZY Buy
- Analyst Count
- FKWL 0
- INZY 9
- Target Price
- FKWL N/A
- INZY $15.22
- AVG Volume (30 Days)
- FKWL 44.1K
- INZY 5.3M
- Earning Date
- FKWL 05-15-2025
- INZY 05-14-2025
- Dividend Yield
- FKWL N/A
- INZY N/A
- EPS Growth
- FKWL N/A
- INZY N/A
- EPS
- FKWL N/A
- INZY N/A
- Revenue
- FKWL $45,276,495.00
- INZY N/A
- Revenue This Year
- FKWL N/A
- INZY N/A
- Revenue Next Year
- FKWL N/A
- INZY N/A
- P/E Ratio
- FKWL N/A
- INZY N/A
- Revenue Growth
- FKWL 8.62
- INZY N/A
- 52 Week Low
- FKWL $2.98
- INZY $0.72
- 52 Week High
- FKWL $7.45
- INZY $6.24
- Technical
- Relative Strength Index (RSI)
- FKWL 37.02
- INZY 85.93
- Support Level
- FKWL $4.00
- INZY $3.94
- Resistance Level
- FKWL $4.20
- INZY $3.97
- Average True Range (ATR)
- FKWL 0.25
- INZY 0.08
- MACD
- FKWL 0.01
- INZY 0.12
- Stochastic Oscillator
- FKWL 48.21
- INZY 99.32
About FKWL Franklin Wireless Corp.
Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.